In this study, we tested whether using ATN-224 to target the non-canonical function of Bcl-2 and other anti-apoptotic proteins could induce cell death in DLBCL cells independent of the level of anti-apoptotic proteins. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.